These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32919923)

  • 1. Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future.
    Kuo S; Ou HT; Wang CJ
    J Am Pharm Assoc (2003); 2021; 61(1):e12-e15. PubMed ID: 32919923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic pharmacy leadership during the COVID-19 crisis: Optimizing patient care through formulary and drug shortage management.
    Pulk RA; Leber M; Tran L; Ammar M; Amin N; Miller L; Yazdi M
    Am J Health Syst Pharm; 2020 Oct; 77(22):1874-1884. PubMed ID: 32710774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages.
    Piatek OI; Ning JC; Touchette DR
    Am J Health Syst Pharm; 2020 Oct; 77(21):1778-1785. PubMed ID: 32716030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. It Takes a Village…: Contending With Drug Shortages During Disasters.
    Burry LD; Barletta JF; Williamson D; Kanji S; Maves RC; Dichter J; Christian MD; Geiling J; Erstad BL
    Chest; 2020 Dec; 158(6):2414-2424. PubMed ID: 32805237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controls to Minimize Disruption of the Pharmaceutical Supply Chain During the COVID-19 Pandemic.
    Cundell T; Guilfoyle D; Kreil TR; Sawant A
    PDA J Pharm Sci Technol; 2020; 74(4):468-494. PubMed ID: 32467176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies.
    Badreldin HA; Atallah B
    Res Social Adm Pharm; 2021 Jan; 17(1):1946-1949. PubMed ID: 32446652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFDA takes actions to help mitigate supply disruptions or shortages of drug.
    Liu SC; Huang MC; Horng SS
    J Formos Med Assoc; 2020 Oct; 119(10):1459-1460. PubMed ID: 32487452
    [No Abstract]   [Full Text] [Related]  

  • 8. Business and continuity of operations: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.
    Tosh PK; Feldman H; Christian MD; Devereaux AV; Kissoon N; Dichter JR; ;
    Chest; 2014 Oct; 146(4 Suppl):e103S-17S. PubMed ID: 25144857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the COVID-19 Pandemic on Medical Product Procurement, Prices, and Supply Chain in Zimbabwe: Lessons for Supply Chain Resiliency.
    Yemeke TT; Umaru FA; Ferrand RA; Ozawa S
    Glob Health Sci Pract; 2023 Oct; 11(5):. PubMed ID: 37903588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and Drug Shortages: A Call to Action.
    Shuman AG; Fox ER; Unguru Y
    J Manag Care Spec Pharm; 2020 Aug; 26(8):945-947. PubMed ID: 32715960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Drug Shortage Crisis in the United States: Impact on Cancer Pharmaceutical Safety.
    Nonzee NJ; Luu TH
    Cancer Treat Res; 2019; 171():75-92. PubMed ID: 30552658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress and strain on the U.S. drug supply: The intersection of shortages, globalization, counterfeit products, and throw in a global COVID-19 pandemic.
    Farmer KC
    J Am Pharm Assoc (2003); 2021; 61(1):e85-e86. PubMed ID: 33419525
    [No Abstract]   [Full Text] [Related]  

  • 13. Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies.
    Romano S; Galante H; Figueira D; Mendes Z; Rodrigues AT
    Res Social Adm Pharm; 2021 Jan; 17(1):1876-1881. PubMed ID: 32482587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of drug shortages across two countries during pre-pandemic and pandemic times.
    Cameron EE; Bushell MA
    Res Social Adm Pharm; 2021 Sep; 17(9):1570-1573. PubMed ID: 33323334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
    Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Medication Shortages: Effective Strategies to Maintain Continuous Medication Availability for Emergency Medical Services.
    Whitfield D; Bosson N; Habrat D; Telmos J; Watson G; Eckstein M; Kazan C; Gausche-Hill M
    Prehosp Emerg Care; 2020; 24(2):290-296. PubMed ID: 31084511
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19.
    Van Denakker TA; Al-Riyami AZ; Feghali R; Gammon R; So-Osman C; Crowe EP; Goel R; Rai H; Tobian AAR; Bloch EM
    Expert Rev Hematol; 2023; 16(7):501-514. PubMed ID: 37129864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs, drugs--who has the drugs?
    Blair J
    J Healthc Prot Manage; 2012; 28(1):28-32. PubMed ID: 22423518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short and long term impacts of COVID-19 on the pharmaceutical sector.
    Ayati N; Saiyarsarai P; Nikfar S
    Daru; 2020 Dec; 28(2):799-805. PubMed ID: 32617864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of EAHP's 2019 Medicines Shortages Survey.
    Miljković N; Batista A; Polidori P; Kohl S; Horák P
    Eur J Hosp Pharm; 2020 Jul; 27(4):202-208. PubMed ID: 32471816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.